Author

N. P. Krishnan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

J. G. Scott· 2 shared D. Crozier· 1 shared D. F. K. Williamson· 1 shared D. Nichol· 1 shared E. McClure· 1 shared J. Pelesko· 1 shared K. Card· 1 shared L. Chick· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

J. G. Scott

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A low-cost, open-source evolutionary bioreactor and its educational use

V. Gopalakrishnan, D. Crozier, K. Card, L. Chick, N. P. Krishnan, E. McClure, J. Pelesko, D. F. K. Williamson, D. Nichol, S. Mandal, R. A. Bonomo, J. G. Scott

The paper introduces a low-cost, open-source morbidostat for educational use, validated through bacterial resistance experiments and student engagement.

bioRxiv · Sep 1, 2022Bioengineering

Modeling collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy

N. Yoon, N. P. Krishnan, J. G. Scott

The paper develops a dynamical model for optimal sequential drug therapies with collaterally sensitive drugs and shows that shaping tumor heterogeneity followed by drug switching maintains subpopulations effectively.

bioRxiv · Jul 2, 2020 · PreprintCancer Biology